Omniscient (“o8t®”), a global pioneer in the use of AI to decode the human brain, today announced the issuance of a new Category ...
Last week, the U.S. Food and Drug Administration (“FDA”) rung in the new year with a flurry of device-related activity, updating two final guidance documents and withdrawing a guidance published back ...
A streamlined, nurse-led response for hospitalized patients experiencing an acute stroke at a Texas academic medical center ...